Ruilong Nuofu is a provider of minimally invasive and digital surgery solutions, focusing on providing a new generation of robots and digital and intelligent solutions for the field of minimally invasive surgery. Committed to building a minimally invasive and digital technology platform and ecosystem around the operating room. Nuovo has recently completed tens of millions of US dollars in Pre-B round financing, led by LRI Jiangyuan Investment, and all existing shareholders including Eli Lilly Asia Fund, Vivo Capital, Matrix Partners, and GGV Capital participated in the follow-up investment. Yikai Capital acted as the exclusive financial advisor of Ruilong Nuofu in this round of financing. This round of financing will be used to accelerate the development of multi-specialty clinical trials of Ruilong Nuofu modular surgical robot, strengthen the company’s platform product development and clinical capabilities, and increase the company’s talent building efforts.
This article is transferred from: https://www.itjuzi.com/investevent/13732980
This site is only for collection, and the copyright belongs to the original author.